Balraj Kakkar has over 20 years of experience advising global biopharmaceutical companies on enterprise, franchise, and portfolio growth strategies. He has a proven record of helping clients maximize the value of innovation, having supported the launch of more than ten specialty medicines across multiple therapeutic areas and geographies, four of which exceeded $5BN in annual sales. Most recently, he partnered with a leading biopharma company to shape their portfolio strategy and build organizational capabilities for leadership in cardiometabolic diseases.
Prior to joining Lumanity, Balraj was a Partner at ZS, where he was part of their Life Sciences Strategy team, and previously held roles at PwC Strategy&. He began his career at Bristol Myers Squibb where he held various commercial roles, gaining a strong foundation at the intersection of science, strategy, and commercialization.
Balraj is passionate about bridging science and strategy to ensure innovation delivers real-world impact. His work focuses on helping organizations create enduring value for patients and other ecosystem stakeholders while navigating a rapidly evolving healthcare landscape.
He holds an MBA from the Stern School of Business at New York University and an MS in Decision Sciences from Drexel University.